Equities

Zota Health Care Ltd

Zota Health Care Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)563.50
  • Today's Change2.15 / 0.38%
  • Shares traded5.27k
  • 1 Year change+28.65%
  • Beta0.9313
Data delayed at least 15 minutes, as of Nov 14 2024 05:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments101123
Total Receivables, Net557403456
Total Inventory538418289
Prepaid expenses119.910.48
Other current assets, total0.000.000
Total current assets1,116842769
Property, plant & equipment, net1,034609236
Goodwill, net------
Intangibles, net414355
Long term investments4775328
Note receivable - long term1.101.100.95
Other long term assets0.000.000.00
Total assets2,2831,5811,391
LIABILITIES
Accounts payable336265187
Accrued expenses45158.39
Notes payable/short-term debt14700
Current portion long-term debt/capital leases1748924
Other current liabilities, total3537140
Total current liabilities737405360
Total long term debt632363125
Total debt953451149
Deferred income tax------
Minority interest------
Other liabilities, total159.7610
Total liabilities1,384778495
SHAREHOLDERS EQUITY
Common stock258252252
Additional paid-in capital659458458
Retained earnings (accumulated deficit)(18)94187
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.00--0.00
Total equity900804896
Total liabilities & shareholders' equity2,2831,5811,391
Total common shares outstanding262525
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.